Where phosphatidylserine is permitted, and what the file must show
Permission for phosphatidylserine is route-specific. In the EU, a soya-derived route is listed as a novel food with conditions of use and a label designation; in the US, PS is a dietary ingredient supported by GRAS notices; the UK applies a retained framework. Each market file has to show the source, the PS content, the allergen, the contaminants and the claim boundary.
Permission depends on the source route and the market, and the file has to show both before the label is designed.
Four checks, not one
A PS ingredient is checked at four levels: the ingredient route, the food category, the contaminants and the label with its claim. They fail independently. A lot can meet the heavy-metal limits and sit on the wrong novel-food route; a route can be correct and the label omit the soy declaration. A supplier's “EU compliant” statement answers one of the four.
The European Union
Food supplements are governed by Directive 2002/46/EC, which harmonises the vitamin and mineral lists but leaves other substances, including phospholipids, to national rules. That is why a PS product can be sold in one member state and questioned in another. On top sits the novel-food Regulation (EU) 2015/2283: a food not consumed significantly in the EU before 15 May 1997 needs an authorisation, and authorised novel foods appear in the Union list in Regulation (EU) 2017/2470 with their conditions of use.
The Union list contains a route for phosphatidylserine from soya phospholipids, originally authorised by Commission Implementing Decision 2011/513/EU. The entry carries the labelling designation “Soya phosphatidylserine” and a maximum of 3 g per day of phosphatidylserine in food supplements as defined in Directive 2002/46/EC at this review. It also sets use levels for other food categories. Separate entries cover other phospholipid routes, including a soy PS and phosphatidic acid product, egg-yolk phospholipids and fish phospholipids. A sunflower route is not automatically covered by the soya entry; the supplier should point to the entry the material relies on. The certificate should state the source and the PS content so the route can be matched, and the label should use the designation that belongs to that route.
The United States
In the US, PS is marketed as a dietary ingredient under DSHEA. The FDA does not approve dietary supplements or their labels before marketing, so there is no pre-market licence to point to. The framework is safety and labelling: the ingredient must be lawful, the facility follows the dietary-supplement GMPs in 21 CFR 111, and the label follows 21 CFR 101. A new dietary ingredient needs a notification at least 75 days before marketing unless its history of use takes it outside that requirement.
PS has GRAS notices for soy, sunflower and fish sources, and the FDA has responded without question to several of them. GRAS status belongs to a specific substance, source and use, not to the name phosphatidylserine in general; a supplier should say which notice its material relies on. For a supplement, the dietary-ingredient route is the more direct one, with the GRAS file as supporting safety evidence.
The allergen question is decided by the source. Soy is a major food allergen under FALCPA, and soy lecithin is not automatically outside the declaration because it is refined. Handle soy-derived PS as soy unless the allergen file proves otherwise, and ask for the soy protein data behind the statement. Sunflower is not on the US major-allergen list, but it is still an ingredient and should be named.
Contaminants and the specification
| Parameter | Catalog limit | EU supplement ceiling | Note |
|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | Regulation (EU) 2023/915 |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg | Higher levels apply only to specified seaweed products |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | Regulation (EU) 2023/915 |
| Arsenic | ≤2 mg/kg | No harmonised EU maximum | National or customer limits apply |
| Peroxide value | ≤10 meq/kg | Not a regulatory maximum | Oxidation specification, not a contaminant |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Set by the specification | Confirm the customer's criteria |
The catalog limits match or sit below the EU ceilings for lead, cadmium and mercury. Arsenic has no harmonised EU maximum for supplements, so the catalog limit is a customer-facing specification rather than a European legal limit; peroxide and acid values are lipid-quality parameters, not contaminants. The limit applies to the finished product, so run the calculation on the formula as well as the powder. The COA page lists the tests, and the ICP-MS method note explains the elemental panel.
The claim boundary
In the EU and the UK, health claims are governed by Regulation 1924/2006 and the GB register that mirrors it. Only authorised claims may be used, and a claim that is not on the register is not made compliant by a footnote. As of this review, there is no authorised health claim for phosphatidylserine, and PS is not a vitamin or mineral with an NRV, so the usual “high in” nutrition claims do not apply either.
In the US, a structure/function claim is allowed for a dietary supplement with the required disclaimer. A disease claim is not allowed unless it is an authorised qualified health claim; otherwise it turns the product into a drug. The wording decides, and enforcement is on the finished label. The supplier provides the specification; the brand owns the claim.
The safe boundary is the same in all three markets: describe what the material is and how it is tested; do not describe a disease, a disease-related use or a prevention. No disease-related claim belongs on a PS specification, COA or label.
The file a buyer should hold
| Document | What it proves | Common gap |
|---|---|---|
| Specification | Grade, source, limits and methods | No source or allergen line |
| Batch COA | The lot was released against the specification | Results copied from the range |
| Allergen and source statement | Soy or sunflower, with protein data | “Soy-free” claimed for a soy lot |
| Novel-food reference (EU) | Which Union-list entry the route relies on | Generic PS statement, no entry |
| GRAS or NDI reference (US) | The safety route for the source | GRAS cited for a different source |
| SDS and stability data | Handling, storage and shelf life | Shelf life with no study behind it |
| Contaminant and micro data | The lot meets the agreed limits | Panel without methods or LOQs |
The compliance checklist
- Name the exact source and grade, and match it to the route for the destination.
- Confirm the PS content and method on the specification.
- Check the allergen declaration against the source, including soy protein data.
- Compare lead, cadmium, mercury, arsenic and microbiology with the applicable limits.
- Check the label designation, ingredient list, allergen statement and storage condition.
- Keep the claim inside the authorised list; no disease-related wording.
- Hold the COA, specification, SDS, stability data and route reference in one dated file.
- Re-check the route when the source, grade or market changes.
The route references are on the EU regulatory page, the US regulatory page and the UK regulatory page. The allergen list is explained in the Annex II glossary entry, and the source decision on the soy versus sunflower page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation